Steven Cohen’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
Steven Cohen's CRDF Position: Q3 2026 in Review
Steven Cohen sold out of Cardiff Oncology (CRDF) in Q3 2026, closing a stake of 28,385 shares — an estimated $36.9K sold.
Steven Cohen first reported a position in CRDF in Q4 2021 and held it in 3 quarters. The position peaked at $3.02M in Q4 2021. 75 funds tracked by Wall St. Rank hold CRDF as of Q3 2026.
- Steven Cohen reported no remaining Cardiff Oncology position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 28,385 Cardiff Oncology shares in Q3 2026, an estimated $36.9K.
- Steven Cohen first reported a position in Cardiff Oncology in Q4 2021 and held it in 3 quarters.
- Steven Cohen's Cardiff Oncology position peaked at $3.02M in Q4 2021.
- 75 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.